Clinical Problem
Critical-sized bone defects, osteomyelitis, osteosarcoma, osteoporotic fractures, and pathological bone fractures often exceed normal self-healing and require a material that supports repair while delivering active payloads.
Orthopedic Reconstruction
Nanohydroxyapatite-based bone fillers for complex defects, infection, and orthopedic stability.
The orthopedic platform includes NanoCement, OsteoCarrier, antibiotic-loaded bone ceramics, collagen composites, membranes for periosteum healing, and magnesium-based implant research.
nHAP
Bone mineral mimic
2
Granted Indian patents
GLP
Scale-up pathway
Mechanism
Nanohydroxyapatite-based ceramics and composites act as bioactive carriers for antibiotics, anticancer drugs, and regenerative cues while enhancing bone bonding and local stability.
Material Platform
Functionalized bone ceramics, rifampicin-loaded bone ceramics, nanohydroxyapatite-collagen composites, cell-free membranes for periosteum healing, and biodegradable magnesium implant research.
Proof & Translation
Resources describe granted Indian patents for biphasic ceramic carriers and antibiotic-loaded composite bone-active biomaterials, plus GLP manufacturing and scale-up activity.
How It Works
Simulation Linked01
Fill
The injectable or moldable carrier occupies the defect and supports structural continuity.
02
Bond
Nanohydroxyapatite chemistry improves bone-material interface stability.
03
Deliver
Antibiotic or therapeutic payloads can be localized to infectious or pathological bone sites.
Why It Matters
- Single-step delivery to reduce operation time
- High biocompatibility and scalable orthopedic use
- Localized antibiotic or bioactive-compound delivery
- Designed for complex bone pathologies such as osteomyelitis and osteoporosis
Translation Status
Current Status: Test Manufacturing License granted, GLP manufacturing and scale-up